NCCN Guidelines® Insights: Multiple Myeloma, Version 1.2025.
Publication
, Journal Article
Kumar, SK; Callander, NS; Adekola, K; Anderson, LD; Baljevic, M; Baz, R; Campagnaro, E; Costello, C; D'Angelo, C; Derman, B; Devarakonda, S ...
Published in: J Natl Compr Canc Netw
May 2025
The NCCN Guidelines for Multiple Myeloma (MM) provide recommendations for diagnosis, initial workup, treatment, follow-up, and supportive care for patients with MM. These NCCN Guidelines Insights highlight the important updates and changes specific to systemic therapy for patients with newly diagnosed as well as previously treated MM included in Version 1.2025 of the NCCN Guidelines for MM.
Duke Scholars
Published In
J Natl Compr Canc Netw
DOI
EISSN
1540-1413
Publication Date
May 2025
Volume
23
Issue
5
Start / End Page
132 / 140
Location
United States
Related Subject Headings
- Oncology & Carcinogenesis
- Multiple Myeloma
- Medical Oncology
- Humans
- 4203 Health services and systems
- 3211 Oncology and carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
Kumar, S. K., Callander, N. S., Adekola, K., Anderson, L. D., Baljevic, M., Baz, R., … Kumar, R. (2025). NCCN Guidelines® Insights: Multiple Myeloma, Version 1.2025. J Natl Compr Canc Netw, 23(5), 132–140. https://doi.org/10.6004/jnccn.2025.0023
Kumar, Shaji K., Natalie S. Callander, Kehinde Adekola, Larry D. Anderson, Muhamed Baljevic, Rachid Baz, Erica Campagnaro, et al. “NCCN Guidelines® Insights: Multiple Myeloma, Version 1.2025.” J Natl Compr Canc Netw 23, no. 5 (May 2025): 132–40. https://doi.org/10.6004/jnccn.2025.0023.
Kumar SK, Callander NS, Adekola K, Anderson LD, Baljevic M, Baz R, et al. NCCN Guidelines® Insights: Multiple Myeloma, Version 1.2025. J Natl Compr Canc Netw. 2025 May;23(5):132–40.
Kumar, Shaji K., et al. “NCCN Guidelines® Insights: Multiple Myeloma, Version 1.2025.” J Natl Compr Canc Netw, vol. 23, no. 5, May 2025, pp. 132–40. Pubmed, doi:10.6004/jnccn.2025.0023.
Kumar SK, Callander NS, Adekola K, Anderson LD, Baljevic M, Baz R, Campagnaro E, Costello C, D’Angelo C, Derman B, Devarakonda S, Elsedawy N, Godara A, Godby K, Hillengass J, Holmberg L, Htut M, Huff CA, Hultcrantz M, Kang Y, Larson S, Lee HC, Liedtke M, Martin T, Omel J, Robinson T, Rosenberg A, Schroeder MA, Sherbenou D, Suvannasankha A, Valent J, Varshavsky-Yanovsky AN, Vogl D, Kovach E, Kumar R. NCCN Guidelines® Insights: Multiple Myeloma, Version 1.2025. J Natl Compr Canc Netw. 2025 May;23(5):132–140.
Published In
J Natl Compr Canc Netw
DOI
EISSN
1540-1413
Publication Date
May 2025
Volume
23
Issue
5
Start / End Page
132 / 140
Location
United States
Related Subject Headings
- Oncology & Carcinogenesis
- Multiple Myeloma
- Medical Oncology
- Humans
- 4203 Health services and systems
- 3211 Oncology and carcinogenesis